1.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673

2.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
by Mahmoodi, Bakhtawar K, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1649-1661

3.
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
by Fufaa, Gudeta D
Diabetologia, 2014-10-15, Vol.58 (1), p.188-198

4.
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis...
by Bakris, George L, Dr, Prof
The Lancet (British edition), 2010, Vol.375 (9721), p.1173-1181

5.
Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
by Fabiano, Rafaela Cabral Gonçalves
Pediatric nephrology (Berlin, West), 2017-02-23, Vol.32 (7), p.1211-1220

6.
Oxidative Balance Score and Chronic Kidney Disease
by Ilori, Titilayo O
American journal of nephrology, 2015-11, Vol.42 (4), p.320-327

7.
Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents
by Kim, Siah
Pediatric nephrology (Berlin, West), 2016-06-23, Vol.32 (1), p.119-129

8.
Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
by NAKAMURA, T
Diabetologia, 2007, Vol.50 (2), p.490-492

9.
Chronic renal failure after Puumala virus infection
by NOVO, R
Pediatric nephrology (Berlin, West), 1999, Vol.13 (9), p.934-935

10.
Plasma beta endorphin in cirrhosis and renal failure
by Thornton, J R
Gut, 1991-03, Vol.32 (3), p.306-308

11.
Pharmacodynamics of Practolol in Chronic Renal Failure
by Eastwood, J. B
British Medical Journal, 1973-11, Vol.4 (5888), p.320-322

12.
Exchangeable and Total Body Potassium in Patients with Chronic Renal Failure
by Boddy, Keith
British Medical Journal, 1972-01, Vol.1 (5793), p.140-142

13.
Common clinical markers predict end-stage renal disease in children with obstructive uropathy
by McLeod, Daryl J
Pediatric nephrology (Berlin, West), 2018-10-13, Vol.34 (3), p.443-448

14.
Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy
by Titan, S.M
Journal of diabetes and its complications, 2012, Vol.26 (6), p.546-553

15.
Acute kidney injury
by Bellomo, Rinaldo, Prof
The Lancet (British edition), 2012, Vol.380 (9843), p.756-766

16.
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
by Roscioni, S. S
Diabetologia, 2013-02, Vol.56 (2), p.259-267

17.
Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
by Furuhashi, Masato
American journal of hypertension, 2015-01, Vol.28 (1), p.15-21

18.
Management of patients at risk of acute kidney injury
by Vanmassenhove, Jill, MD
The Lancet (British edition), 2017, Vol.389 (10084), p.2139-2151

19.
Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury
by Westhoff, Jens H
European journal of pediatrics, 2017-04-14, Vol.176 (6), p.745-755

20.
Regeneration and experimental orthotopic transplantation of a bioengineered kidney
by Song, Jeremy J
Nature medicine, 2013-05, Vol.19 (5), p.646-651
